PHARMGKB.ORG

Domain Rank: 81,620

Last Updated: May 16, 2024

PHARMGKB.ORG Summary

pharmgkb.org has 3 NS records, 1 A records, 0 AAAA records, 3 MX records, and 1 TXT records. Name servers for pharmgkb.org are atalante.stanford.edu, argus.stanford.edu, avallone.stanford.edu. A records for pharmgkb.org are 171.67.192.2. MX records that process @pharmgkb.org email are alt1.aspmx.l.google.com, aspmx.l.google.com, alt2.aspmx.l.google.com. We have observed pharmgkb.org to have 6 subdomains. A subdomain count of 6 is considered a small digital footprint. Technology that may be in use at pharmgkb.org includes google. The domain's primary website is hosted on a nginx web server at 171.67.192.2 in United States. As of May 16, 2024, pharmgkb.org does not have any threat intelligence reports of concern.

Search DigitalStakeout Footprint to find another asset.

PHARMGKB.ORG DNS Records

A Records

171.67.192.2

AAAA Records

No DNS AAAA records

TXT Records

pharmgkb.org. 1800 IN TXT "google-site-verification=DfRnGd7isP8ak_5Pkq9C9Uko2sXg061w5TSx58Vf8PU"

Search DigitalStakeout Footprint to find another asset.

PHARMGKB.ORG Subdomains

pharmgkb.org has 6 subdomains in our inventory.

Hostname IP Address
consortia.pharmgkb.org 185.199.111.153
pharmgkb.org 171.67.192.2
pgkb-markwoon-ananke.pharmgkb.org 171.64.30.76
greenlantern.pharmgkb.org 171.67.192.53
pgkb-markwoon-halo.pharmgkb.org 171.64.30.79
pgkb-dongle-1.pharmgkb.org 171.64.30.9

Search DigitalStakeout Footprint to find another asset.

PHARMGKB.ORG Website

Web Server

nginx

IP Address

171.67.192.2

Country

United States

Meta Tags

og:site_name: pharmgkb

og:publisher: https://www.facebook.com/pharmgkb

Search DigitalStakeout Footprint to find another asset.

PHARMGKB.ORG Certificate Trust

Certificate Trust Log

{"message_type": "certificate_update", "data": {"leaf_cert": {"not_after": 1702857599, "signature_algorithm": "sha256, rsa", "extensions": {"subjectKeyIdentifier": "3C:54:D4:D3:CB:7F:31:D8:EB:8E:B1:BD:60:87:B7:EB:44:77:1B:9C", "authorityKeyIdentifier": "keyid:8D:8C:5E:C4:54:AD:8A:E1:77:E9:9B:F9:9B:05:E1:B8:01:8D:61:E1\n", "extendedKeyUsage": "TLS Web server authentication, TLS Web client authentication", "subjectAltName": "DNS:pharmgkb.org, DNS:*.pharmgkb.org", "keyUsage": "Digital Signature, Key Encipherment", "certificatePolicies": "Policy: 2.23.140.1.2.1\nPolicy: 1.3.6.1.4.1.6449.1.2.2.7\n CPS: https://sectigo.com/CPS", "ctlSignedCertificateTimestamp": "BIIBaQFnAHcArfe--nz_EMiLnT2cHj4YarRnKV3PsQwkyoWGNOvcgooAAAGEggtZAgAABAMASDBGAiEApXeybvVFn-Iy5PZp2-Jxf21AStmnS18pUxQc5i0r5u0CIQDQmWwZe8eP-JxFNujIn2_X8cNTyCAaAcTNd7AdtZrHAwB1AHoyjFTYty22IOo44FIe6YQWcDIThU070ivBOlejUutSAAABhIILWOUAAAQDAEYwRAIgc4WAhSodytOepAGqfQct8TeeWn59oOsmfrrDd30jO6wCICj15IW-_BWen6tliojPx1691MOS_VlXubGBCHMdPr5YAHUA6D7Q2j71BjUy51covIlryQPTy9ERa-zraeF3fW0GvW4AAAGEggtYmgAABAMARjBEAiAWqdv7mVax_v0xj_48wlqEhgSm1z51R_lxACIkEgNKKQIgDbRta2lA1t_zbcmwqeEPIk0wcFfF6MtoSWxoajf7_V4=", "authorityInfoAccess": "OCSP - URI:http://ocsp.sectigo.com\nCA Issuers - URI:http://crt.sectigo.com/SectigoRSADomainValidationSecureServerCA.crt\n", "basicConstraints": "CA:FALSE"}, "fingerprint": "AC:8A:9F:CC:BB:8C:60:27:EE:C5:16:70:91:DD:45:CB:43:19:18:43", "all_domains": ["*.pharmgkb.org", "pharmgkb.org"], "serial_number": "9CCA1AD10F6DE9E7351B135143C1A881", "subject": {"C": null, "CN": "*.pharmgkb.org", "L": null, "O": null, "ST": null, "emailAddress": null, "OU": null, "aggregated": "/CN=*.pharmgkb.org"}, "not_before": 1668556800, "issuer": {"C": "GB", "CN": "Sectigo RSA Domain Validation Secure Server CA", "L": "Salford", "O": "Sectigo Limited", "ST": "Greater Manchester", "emailAddress": null, "OU": null, "aggregated": "/C=GB/CN=Sectigo RSA Domain Validation Secure Server CA/L=Salford/O=Sectigo Limited/ST=Greater Manchester"}}, "cert_link": "https://sabre.ct.comodo.com/ct/v1/get-entries?start=230256750&end=230256750", "source": {"url": "https://sabre.ct.comodo.com/", "name": "Sectigo 'Sabre' CT log"}, "update_type": "X509LogEntry", "seen": 1681137685.270417, "cert_index": 230256750}}

Search DigitalStakeout Footprint to find another asset.